These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 898652)

  • 41. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ
    Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mutations in hepatitis B virus DNA from patients with coexisting HBsAg and anti-HBs.
    Chen Y; Qian F; Yuan Q; Li X; Wu W; Guo X; Li L
    J Clin Virol; 2011 Nov; 52(3):198-203. PubMed ID: 21840251
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Post-transfusion hepatitis: the role of hepatitis B antibody.
    Koretz RL; Overby LR; Gitnick GL
    Gastroenterology; 1976 Apr; 70(4):556-61. PubMed ID: 56285
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Possibilities of using UV-irradiated blood in the prevention of serum hepatitis after blood transfusions during surgery].
    Marchenko AV; Dutkevich IG; Golovin GV; Vykhodtseva VA
    Vestn Khir Im I I Grek; 1990 Feb; 144(2):87-9. PubMed ID: 2165696
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Occurrence of HBsAg, anti-HBs, the anti-CMV following the transfusion of blood products.
    Contreras TJ; Lang DJ; Pivacek LE; Valeri CR
    Transfusion; 1979; 19(2):129-36. PubMed ID: 219565
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Post-transfusion hepatitis in Australia. Report of the Australian Red Cross study.
    Cossart YE; Kirsch S; Ismay SL
    Lancet; 1982 Jan; 1(8265):208-13. PubMed ID: 6119566
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transfusion of hepatitis B immune complex-containing blood in high HBV prevalence populations.
    Simons MJ
    Am J Med Sci; 1975; 270(2):349-54. PubMed ID: 1235477
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Hepatitis in hemophiliacs with multiple transfusions].
    Filová A; Hrubisková K; Hrubisko M; Malícková D; Nováková J; Pokorná G
    Vnitr Lek; 1982 Mar; 28(3):230-6. PubMed ID: 7112967
    [No Abstract]   [Full Text] [Related]  

  • 49. [Etiology and prevention of post-transfusion hepatitis upon systematic screening of donor sera].
    Kirilenko VA; Anan'ev VA
    Vopr Virusol; 1989; 34(5):621-3. PubMed ID: 2609651
    [No Abstract]   [Full Text] [Related]  

  • 50. Clinical and serological analysis of transfusion-associated hepatitis.
    Alter HJ; Holland PV; Morrow AG; Purcell RH; Feinstone SM; Moritsugu Y
    Lancet; 1975 Nov; 2(7940):838-41. PubMed ID: 53329
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [HBsAg-negative post-transfusion hepatitis (author's transl)].
    Hernández Sánchez JM; Vargas V; Pedreira JD; Esteban R; Ruíz J; Guardia J; Bacardi R
    Sangre (Barc); 1979; 24(2):143-7. PubMed ID: 462333
    [No Abstract]   [Full Text] [Related]  

  • 52. A clinical and laboratory evaluation of immune serum globulin from donors with a history of hepatitis: attempted prevention of post-transfusion hepatitis.
    Kuhns WJ; Prince AM; Brotman B; Hazzi C; Grady GF
    Am J Med Sci; 1976; 272(3):255-61. PubMed ID: 65126
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Serologic and clinical study of post-transfusion viral contamination after cardiac surgery. Excluding human immunodeficiency virus].
    Petitjean J; Khayat MC; Laforet F; Quibriac M; Freymuth F; Khayat A; Evrard C; Thomas M
    Arch Mal Coeur Vaiss; 1988 Oct; 81(10):1199-203. PubMed ID: 2851964
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Serological classification of post-transfusion hepatitis (author's transl)].
    Lehmann H; Schlaak M
    Immun Infekt; 1979 Dec; 7(6):187-95. PubMed ID: 540971
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatitis B due to transfusion of mislabeled blood.
    Seder RH; Chopra S; Schumacher R; Koff RS
    Transfusion; 1981; 21(3):363-5. PubMed ID: 7233522
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Post-transfusion hepatitis: can the problem be solved today? (author's transl)].
    Stute R; Staudacher B; Krian A; Brüster H
    Dtsch Med Wochenschr; 1980 Feb; 105(8):266-9. PubMed ID: 7353503
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk factors in transmission of non-A, non-B posttransfusion hepatitis. The role of hepatitis B antibody in donor blood.
    Conrad ME; Knodell RG; Bradley EL; Flannery EP; Ginsberg AL
    Transfusion; 1977; 17(6):579-85. PubMed ID: 595112
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Late sequelae of tumor treatment in childhood: HBsAg persistance and liver diseases].
    Baumann W; Gutjahr P; Arnold W; Meyer zum Büschenfelde KH
    Monatsschr Kinderheilkd (1902); 1977 May; 125(5):574-5. PubMed ID: 559930
    [No Abstract]   [Full Text] [Related]  

  • 59. Letter: Risk of transfusing blood containing anti-HBS.
    Fielder H
    Lancet; 1975 Feb; 1(7902):341. PubMed ID: 46488
    [No Abstract]   [Full Text] [Related]  

  • 60. [Detection and prophylaxis of post-transfusion viral hepatitis].
    Heusghem C; Plomteux G; Otto-Servais M; André A; Brocteur J; Buret J; Mersch G; Lennes G
    Rev Med Liege; 1972 Jan; 27(1):13-9. PubMed ID: 5036330
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.